Injectable & IV Drugs recalls

The FDA has published 4,626 recalls involving injectable & iv drugs since 2012. The latest was reported on 9 Oct 2026. Most were for sterility. The Compounding Pharmacy of America has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4,626since 2012

Last 12 months187reported

Class I2545% of total

Ongoing518latest 9 Oct 2026

Recalls per month, last 24 months

click a bar for that month

3Nov '24 6 5 3Feb 8 13 9May 1 15 6Aug 9 59 4Nov 11 3 5Feb 4 29 10May 3 12 22Aug 21 4

Severity split

Class I 254 5%Class II 4,181 90%Class III 186 4%Other/pending 5

Why injectable & iv drugs is recalled

Companies

The Compounding Pharmacy of America2245%
Vita Pharmacy1273%
Central Admixture Pharmacy Services1092%
Pharmedium Services1092%
Hospira972%
Franck's Lab Inc., d.b.a. Franck's Compounding Lab952%
Wells Pharmacy Network942%
Assurance Infusion922%

Brands

By year

20261132%
20251433%
2024872%
20233017%
20223548%
20212475%
20202315%
201955012%
20183227%
20173357%

Ongoing injectable & iv drugs recalls

518 active

Reported	Class	Recall	Company	Reason	Where
9 Oct 2026Drug	ANNOUNCED	Par Pharmaceutical Brevital Sodium 500 mg/vial for Injection recalledPar Pharmaceutical	Par Health	Particulate Matter	Nationwide
7 Oct 2026Drug	CLASS II	Buprenorphine Hydrochloride, Injection 0.3 mg/mL recalledBuprenorphine Hydrochloride	Par Health USA	Other	Nationwide
7 Oct 2026Drug	CLASS II	Focus PI Hypromellose 0.7% Formula, 0.3 FL O per vial, Sterile recalledFocus Pi	Aurolab Trust	Sterility	VA
1 Oct 2026Drug	ANNOUNCED	Greewich Glutathione Injection recalled by Greenwich RxGreewich	Greenwich Rx	Packaging Defects	Nationwide
30 Sep 2026Drug	CLASS II	Exenatide Injection, USP, 250 mcg/mL per prefilled pen recalledExenatide	Amneal Pharmaceuticals of New York	Other	Nationwide
23 Sep 2026Drug	CLASS II	Dopamine HCl Inj., USP, 200 mg/ (40 mg/mL) Single-dose recalledDopamine Hydrochloride	Pfizer	Sterility	Nationwide

All injectable & iv drugs recalls, newest first

4,626 total

Reported	Class	Recall	Company	Reason	Where
9 Oct 2026Drug	ANNOUNCED	Par Pharmaceutical Brevital Sodium 500 mg/vial for Injection recalledPar Pharmaceutical	Par Health	Particulate Matter	Nationwide
7 Oct 2026Drug	CLASS II	Buprenorphine Hydrochloride, Injection 0.3 mg/mL recalledBuprenorphine Hydrochloride	Par Health USA	Other	Nationwide
7 Oct 2026Drug	CLASS II	Focus PI Hypromellose 0.7% Formula, 0.3 FL O per vial, Sterile recalledFocus Pi	Aurolab Trust	Sterility	VA
1 Oct 2026Drug	ANNOUNCED	Greewich Glutathione Injection recalled by Greenwich RxGreewich	Greenwich Rx	Packaging Defects	Nationwide
30 Sep 2026Drug	CLASS II	Exenatide Injection, USP, 250 mcg/mL per prefilled pen recalledExenatide	Amneal Pharmaceuticals of New York	Other	Nationwide
23 Sep 2026Drug	CLASS II	Dopamine HCl Inj., USP, 200 mg/ (40 mg/mL) Single-dose recalledDopamine Hydrochloride	Pfizer	Sterility	Nationwide
21 Sep 2026Drug	ANNOUNCED	ICU Medical LLC 0.9% Sodium Chloride Injection recalledICU Medical LLC	Otsuka ICU Medical	Packaging Defects
21 Sep 2026Drug	ANNOUNCED	Par Pharmaceutical Dexmedetomidine HCl recalled by Par HealthPar Pharmaceutical	Par Health	Particulate Matter	Nationwide
16 Sep 2026Drug	CLASS I	Dextrose Injection, USP, 70 % recalled by Baxter Healthcare	Baxter Healthcare	Particulate Matter	Nationwide
16 Sep 2026Drug	CLASS I	0.9% Sodium Chloride Injection, USP Partial Fill recalledSodium Chloride	B Braun Medical	Particulate Matter	Nationwide
13 Sep 2026Drug	ANNOUNCED	Compounded Glutathione 200 mg/mL multidose vial recalledCentric Compounding	Centric Compounding	Packaging Defects	Nationwide
9 Sep 2026Drug	CLASS III	Revcovi (elapegademase-lvlr) Injection, 2.4mg/ (1.6 mg/mL) recalledRevcovi	Chiesi USA	Potency & Assay	MO, TN
9 Sep 2026Drug	CLASS I	0.9% Sodium Chloride Injection USP, Viaflex recalledSodium Chloride	Baxter Healthcare	Particulate Matter	IL
9 Sep 2026Drug	CLASS I	Glutathione 200 mg/mL sterile multidose vial recalled	Optimal Balance Pharmacy	Sterility	Nationwide
9 Sep 2026Drug	CLASS II	Carton label: Mycophenolate Mofetil for injection recalledMycophenolate Mofetil	Mylan Pharmaceuticals	Potency & Assay	Nationwide
9 Sep 2026Drug	CLASS II	Vasopressin, in 0.9% Sodium Chloride Injection per/mL) recalledVasopressin In 0.9% Sodium Chloride	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Dexmedetomidine Hydrochloride recalled by Baxter Healthcare	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Nexterone (amiodarone HCI), 360 mg/ (1.8 mg/mL) recalledNexterone	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg recalled	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Cardene IV (Nicardipine Hydrochloride) recalled by Baxter HealthcareCardene Iv	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg recalled	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Vasopressin, in 0.9% Sodium Chloride Injection per/mL) recalledVasopressin In 0.9% Sodium Chloride	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
2 Sep 2026Drug	CLASS I	Lactated Ringer's Injection USP Excel container recalledLactated Ringers	B Braun Medical	Particulate Matter	Nationwide
2 Sep 2026Drug	CLASS I	Tyenne (tocilizumab-aazg) Injection, 400 mg/ (20 mg/mL) vial recalledTyenne	Fresenius Kabi USA	Particulate Matter	Nationwide
2 Sep 2026Drug	CLASS II	Acthar Gel (repository corticotropin injection) multiple-dose vial recalledActhar	Mallinckrodt Hospital Products	Particulate Matter	Nationwide
26 Aug 2026Drug	CLASS II	Tralement (trace elements injection 4*, USP) recalled by American RegentTralement	American Regent	Particulate Matter	Nationwide
26 Aug 2026Drug	CLASS II	Cyanocobalamin injection USP, 1,000 mcg/mL, For IM or SC Use Only recalledCyanocobalamin	American Regent	Particulate Matter	Nationwide
26 Aug 2026Drug	CLASS II	Selenious Acid Injection, USP 12 mcg/ (6 mcg/, For intravenous use recalledSelenious Acid	American Regent	Particulate Matter	Nationwide
26 Aug 2026Drug	CLASS II	Aminaocaproic Acid Injection, USP, 250 mg/mL recalled by American RegentAminocaproic Acid	American Regent	Particulate Matter	Nationwide
26 Aug 2026Drug	CLASS II	niCARdipine Hydrochloride Injection, USP, 25 mg/ (2.5 mg/mL) recalledNicardipine Hydrochloride	American Regent	Particulate Matter	Nationwide

Should you stop taking Injectable & IV Drugs?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.

Alert me about Injectable & IV Drugs

One email the day a new recall is posted for Injectable & IV Drugs. Unsubscribe any time.

At a glance

Latest recall: 9 Oct 2026
First on record: 20 Jun 2012
Class I share: 5%
Ongoing: 518

Drug classes

Injectable & IV Drugs 4,626Pain Medication 1,518Creams, Ointments & Gels 930Blood Pressure Medication 837Compounded Drugs 721Eye Drops 600Hormones & Birth Control 495Antibiotics 492Allergy Medication 348Stomach & Acid Reflux Medication 313Cold & Cough Medicine 312Diabetes Medication 242

Recall classes

CLASS ISerious harm or death possible.

CLASS IITemporary or reversible harm.

CLASS IIIUnlikely to cause harm.